Announcements

SharonAI Holdings Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on August 27, 2026, disclosing the appointment of David Burns, age 60, as Chief Operating Officer, effective September 7, 2026.

Under Armour, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on August 27, 2026, reporting the voting results from its Annual Meeting of Stockholders held on August 26, 2026.

Alto Neuroscience, Inc. (NYSE:ANRO) filed a Form 8-K on August 27, 2026, reporting the promotion of Nicholas C. Smith from Chief Financial Officer and Chief Business Officer to President and Chief Financial Officer, effective August 26, 2026, along with a $6,000,000 cash retention agreement.

Solstice Advanced Materials Inc. filed a Form 8-K on August 27, 2026, disclosing the mutual termination of its Agreement and Plan of Merger with Element Solutions Inc. and announcing a new $500 million share repurchase program.

Lam Research Corporation filed an 8-K with the U.S. Securities and Exchange Commission on August 27, 2026, disclosing that two members of its Board of Directors notified the company of their decisions to retire effective November 2, 2026.

George Kurtz, President and CEO of CrowdStrike Holdings, Inc. (NASDAQ:CRWD), filed a Form 4 on August 27, 2026, disclosing the sale of Class A common stock across multiple transactions on August 25 and August 26, 2026, pursuant to a Rule 10b5-1 plan.

Roivant Sciences Ltd. filed a Form 8-K on August 27, 2026, disclosing that the U.S. Food and Drug Administration approved the New Drug Application for LISRAYA (brepocitinib) for the treatment of adults with dermatomyositis.